Glucose metabolism alterations in patients with bipolar disorder

Journal of Affective Disorders

Volumn 184, Issue , 2015, Pages 293-298

  Rosso, Gianluca ^a   Cattaneo, Annamaria ^b,c   Zanardini, Roberta ^b   Gennarelli, Massimo ^b,d   Maina, Giuseppe ^a   Bocchio Chiavetto, Luisella ^b,e  

^a UNIVERSITY OF TURIN   (Italy)

^b IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF BRESCIA   (Italy)

^e ECAMPUS UNIVERSITY   (Italy)

Author keywords

Bipolar disorder; Ghrelin; Glucagon; Incretins; Metabolic syndrome; Serum

Indexed keywords

BIOLOGICAL MARKER; C PEPTIDE; GASTRIC INHIBITORY POLYPEPTIDE; GHRELIN; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; INSULIN; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESISTIN; GLUCOSE BLOOD LEVEL; SERPINE1 PROTEIN, HUMAN;

ADULT; ARTICLE; BIPOLAR DISORDER; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GLUCOSE METABOLISM; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PERSONALIZED MEDICINE; PRIORITY JOURNAL; SYMPTOMATOLOGY; BLOOD; CASE CONTROL STUDY; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED;

BIOMARKERS; BIPOLAR DISORDER; BLOOD GLUCOSE; C-PEPTIDE; CASE-CONTROL STUDIES; FEMALE; GASTRIC INHIBITORY POLYPEPTIDE; GHRELIN; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INSULIN; LEPTIN; MALE; MIDDLE AGED; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESISTIN;

EID: 84933507654     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2015.06.006     Document Type: Article

References (40)

1. E. Alvarez, M.D. Martinez, I. Roncero, J.A. Chowen, B. Garcia-Cuartero, and J.D. Gispert The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem J. Neurochem. 92 2005 798 806
2. M. Alvarez-Crespo, K.P. Skibicka, I. Farkas, C.S. Molnár, E. Egecioglu, E. Hrabovszky, Z. Liposits, and S.L. Dickson The amygdala as a neurobiological target for ghrelin in rats: neuroanatomical, electrophysiological and behavioral evidence PLoS One 7 10 2012 e46321
3. W.A. Banks, and A.J. Kastin Peptides and the blood-brain barrier: lipophilicity as a predictor of permeability Brain Res. Bull. 15 1985 287 292
4. I.G. Barbosa, N.P. Rocha, and A.S. de Miranda Increased adipokines in bipolar disorder J. Psychiatr. Res. 46 2012 386 393
5. A.L. Beynon, M.R. Brown, R. Wright, M.I. Rees, I.M. Sheldon, and J.S. Davies Ghrelin inhibits LPS-induced release of IL-6 from mouse dopaminergic neurones J. Neuroinflamm. 19 2013 40
6. M. Berk, K.T. Hallam, and P.D. McGorry The potential utility of a staging model as a course specifier: a bipolar disorder perspective J. Affect. Disord. 100 2007 279 281
7. G.S. Birketvedt, J. Florholmen, J. Sundsfjord, B. Osterud, D. Dinges, W. Bilker, and A. Stunkard Behavioral and neuroendocrine characteristics of the night-eating syndrome J. Am. Med. Assoc. 282 1999 657 663
8. S. Bo, G. Ciccone, and N. Pearce Prevalence of undiagnosed metabolic syndrome in a population of adult asymptomatic subjects Diabetes Res. Clin. Pract. 75 2007 362 365
9. E.J. Canales-Rodríguez, E. Pomarol-Clotet, J. Radua, S. Sarró, S. Alonso-Lana, C. Del Mar Bonnín, J.M. Goikolea, T. Maristany, R. García-Álvarez, E. Vieta, P. McKenna, and R. Salvador Structural abnormalities in bipolar euthymia: a multicontrast molecular diffusion imaging study Biol. Psychiatry 76 2014 239 248
10. F.F. Chehab, K. Mounzih, R. Lu, and M.E. Lim Early onset of reproductive function in normal female mice treated with leptin Science 275 1997 88 90
11. L. Czepielewski, L. Daruy Filho, E. Brietzke, and R. Grassi-Oliveira Bipolar disorder and metabolic syndrome: a systematic review Rev. Bras. Psiquiatr. 35 2013 88 93
12. J.L. Dunphy, R.G. Taylor, and P.J. Fuller Tissue distribution of rat glucagon receptor and GLP-1 receptor gene expression Mol. Cell. Endocrinol. 141 1998 179 186
13. A. Fagiolini, E. Frank, S. Turkin, P.R. Houck, I. Soreca, and D.J. Kupfer Metabolic syndrome in patients with bipolar disorder J. Clin. Psychiatry 69 2008 678 679
14. J. Fox Applied Regression, Linear Models, and Related Methods 1997 Sage Publications, Inc. Thousand Oaks, CA, US
15. S.M. Grundy, J.I. Cleeman, and S.R. Daniels American Heart Association, National Heart, Lung, and Blood Insitute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart Lung, and Blood Institute Scientific Statement Circulation 2005 112 2005 2735 2752
16. F. Kapczinski, P.V. Magalhães, and V. Balanzá-Martinez Staging systems in bipolar disorder: an International Society for Bipolar Disorders task force report Acta Psychiatr. Scand. 130 5 2014 354 363
17. M. Kluge, D. Schmidt, M. Uhr, and A. Steiger Ghrelin suppresses nocturnal secretion of luteinizing hormone (LH) and thyroid stimulating hormone (TSH) in patients with major depression J. Psychiatr. Res. 47 2013 1236 1239
18. A.L. Lopresti, and P.D. Drummond Obesity and psychiatric disorders: commonalities in dysregulated biological pathways and their implications for treatment Prog. Neuropsychopharmacol. Biol. Psychiatry 45 2013 92 99
19. A.L. Lopresti, G.L. Maker, S.D. Hood, and P.D. Drummond A review of peripheral biomarkers in major depression: the potential of inflammatory and oxidative stress biomarkers Prog. Neuropsychopharmacol. Biol. Psychiatry 3 2014 102 111
20. C.K. Martin, H. Han, S.D. Anton, F.L. Greenway, and S.R. Smith Effect of valproic acid on body weight, food intake, physical activity and hormones: results of a randomized controlled trial J. Psychopharmacol. 23 7 2009 814 825
21. S.L. McElroy, and P.E. Keck Jr. Metabolic syndrome in bipolar disorder: a review with a focus on bipolar depression J. Clin. Psychiatry 75 2014 46 61
22. R.S. McIntyre, N.L. Rasgon, and D.E. Kemp Metabolic syndrome and major depressive disorder: co-occurrence and pathophysiologic overlap Curr. Diabetes Rep. 9 2009 51 59
23. R.S. McIntyre, M. Danilewitz, and S.S. Liauw Bipolar disorder and metabolic syndrome: an international perspective J. Affect. Disord. 126 2010 366 387
24. R.S. McIntyre, D.S. Cha, and J.M. Jerrell Obesity and mental illness: implications for cognitive functioning Adv. Ther. 30 2013 577 588
25. M. Méquinion, F. Langlet, and S. Zgheib Ghrelin: central and peripheral implications in anorexia nervosa Front. Endocrinol. 4 2013 15
26. K.R. Merikangas, R. Jin, and J.P. He Prevalence and correlates of bipolar spectrum disorder in the World Mental Health Survey Initiative Arch. Gen. Psychiatry 68 2011 241 251
27. S. Miyake, and T. Yamamura Ghrelin: friend or foe for neuroinflammation Discov. Med. 8 2009 64 67
28. R.J. Perry, X.M. Zhang, D. Zhang, N. Kumashiro, J.P. Camporez, G.W. Cline, D.L. Rothman, and G.I. Shulman Leptin reverses diabetes by suppression of the hypothalamic-pituitary-adrenal axis Nat. Med. 20 7 2014 759 763
29. M. Rauchenzauner, M. Laimer, M. Wiedmann, A. Tschoner, K. Salzmann, W. Sturm, A. Sandhofer, G. Walser, G. Luef, and C.F. Ebenbichler The novel insulin resistance parameters RBP4 and GLP-1 in patients treated with valproic acid: just a sidestep? Epilepsy Res. 104 3 2013 285 288
30. Â. Roda, I. Chendo, and M. Kunz Biomarkers and staging of bipolar disorder: a systematic review Trends Psychiatry Psychother. 37 1 2015 3 11
31. G. Rosso, U. Albert, F. Bogetto, and G. Maina Axis II comorbidity in euthymic bipolar disorder patients: no differences between bipolar I and II subtypes J. Affect. Disord. 115 2009 257 261
32. V. Salvi, V. D'Ambrosio, G. Rosso, F. Bogetto, and G. Maina Age-specific prevalence of metabolic sindrome in Italian patients with bipolar disorders Psychiatry Clin. Neurosci. 65 2011 47 54
33. J.K. Soczynska, S.H. Kennedy, and H.O. Woldeyohannes Mood disorders and obesity: understanding inflammation as a pathophysiological nexus Neuromol. Med. 13 2011 93 116
34. M.G. Soerio-de-Souza, P.W. Gold, and A.R. Brunoni Lithium decreases plasma adiponectin levels in bipolar depression Neurosci. Lett. 3 2014 111 114
35. K.L. Teff, M.R. Rickels, J. Grudziak, C. Fuller, H.L. Nguyen, and K. Rickels Antipsychotic-induced insulin resistance and postprandial hormonal dysregulation independent of weight gain or psychiatric disease Diabetes 62 2013 3232 3240
36. D. Vancampfort, K. Vansteelandt, C.U. Correll, A.J. Mitchell, A. De Herdt, P. Sienaert, M. Probst, and M. De Hert Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators Am. J. Psychiatry 170 2013 265 274
37. A. Vella, and R.A. Rizza Extrapancreatic effects of GIP and GLP-1 Horm. Metab. Res. 36 2004 830 836
38. T. Vos, A.D. Flaxman, and M. Naghavi Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2012 2163 2196
39. Y. Wang, S. Zhong, Z. Zhou, Q. Zhou, and L. Huang Reduced interhemispheric resting-state functional connectivity in unmedicated bipolar II disorder Acta Psychiatr. Scand. 30 2015 1 9
40. J.M. Zigman, J.E. Jones, and C.E. Lee Expression of ghrelin receptor mRNA in the rat and the mouse brain J. Comp. Neurol. 494 2006 528 548